October 16, 2016
1 min read
Save

Four named to leadership roles at University of Michigan Comprehensive Cancer Center

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

The University of Michigan Comprehensive Cancer Center appointed four people to leadership positions to help oversee its research operations.

Pavan Reddy, MD, will serve as deputy director. Reddy, recognized for his understanding of the prevention and treatment of graft-versus-host disease, also is division chief of hematology and oncology at University of Michigan. He will serve a vital role in the center’s overall strategy and research direction.

Alnawaz Rehemtulla, PhD, will serve as associate director for shared resources. Rehemtulla is professor of radiation oncology and professor of radiology at University of Michigan. His research interests include molecular imaging, mouse models of cancer, and the discovery and development of therapeutic molecules.

Anne Schott, MD, will serve as associate director for clinical research. Schott, a professor of hematology/oncology, treats patients with breast cancer and serves as principal investigator on several clinical trials.

Stephen J. Weiss, MD, will serve as associate director for basic science research. Weiss is professor of medicine and oncology, as well as a research professor at University of Michigan Life Sciences Institute. He will oversee the cancer center’s four basic science research programs.

“These individuals have demonstrated a commitment to excellence, collaboration and innovation in their research and leadership,” Eric Fearon, MD, PhD, director of University of Michigan Comprehensive Cancer Center, said in a press release “I am confident this outstanding leadership team will have a major positive impact in advancing our mission of making discoveries that will transform cancer prevention, therapy and survival.”